ProfileGDS4459 / ENSG00000105197
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 82% 66% 89% 79% 74% 68% 86% 84% 84% 89% 70% 82% 84% 65% 84% 61% 52% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 16.182
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.9866
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 37.2989
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 45.7579
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 55.6274
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 65.1668
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 76.7686
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 86.5984
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 96.6184
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 107.0789
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.2370
GSM623475group B, liver allograft wedge biopsie placebo treatment 26.4882
GSM623476group B, liver allograft wedge biopsie placebo treatment 36.5384
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.9465
GSM623478group B, liver allograft wedge biopsie placebo treatment 56.6484
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.7661
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.4552